Evidence map›Paper›PMID 38473347›Full record

ArticleCancers2024

The Additional Value of Somatostatin Receptor Positron Emission Computed Tomography ([

Carolijn J M de Bresser, Bart-Jeroen Petri, Arthur J A T Braat, Bart de Keizer, Mark J C van Treijen, Jan Willem Dankbaar, Frank A Pameijer, Marius G J Kok, Mischa de Ridder, Bernadette P M van Nesselrooij and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Carolijn J M de BresserDepartment of Vascular Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
Bart-Jeroen PetriDepartment of Vascular Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.
Arthur J A T BraatDepartment of Radiology and Nuclear Medicine, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.ORCID 0000-0002-8824-8697
Bart de KeizerDepartment of Radiology and Nuclear Medicine, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.ORCID 0000-0002-6270-9483
Mark J C van TreijenDepartment of Endocrine Oncology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Jan Willem DankbaarDepartment of Radiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Frank A PameijerDepartment of Radiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Marius G J KokDepartment of Radiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Mischa de RidderDepartment of Radiotherapy, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.ORCID 0000-0002-2530-3038
Bernadette P M van NesselrooijDepartment of Clinical Genetics, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
Remco de BreeDepartment of Head and Neck Surgical Oncology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.ORCID 0000-0001-7128-5814
Gert J de BorstDepartment of Vascular Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.ORCID 0000-0002-1389-4141
Johannes A RijkenDepartment of Head and Neck Surgical Oncology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
University Medical Center Utrecht · NLHeidelberg University · DEMedisch Spectrum Twente · NLThe Netherlands Cancer Institute · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Dutch guideline for patients suspected of head and neck paragangliomas (HNPGLs) recommends magnetic resonance imaging (MRI) and/or computed tomography (CT) of the head and neck area. Additionally, it suggests considering additional nuclear imaging. The aim of this study was to evaluate the outcomes of [

methodsIn this single-center pilot study, retrospective data were obtained from consecutive patients between 2016 and 2023. Both MRI and [

resultsA total of 25 consecutive patients were included, and 7 patients (28.0%,

conclusionsThe authors recommend performing baseline imaging with [

Indexed as

[68Ga]Ga-DOTATOC PET/CThead and neck paragangliomaMRI

Identifiers

PMID38473347
PMCPMC10931364
OpenAlexW4392241846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.